Sie sind auf Seite 1von 4

Global Cardiovascular Device Market was valued US$ XX Bn.

in 2019 and is
expected to reach US$ XX Bn. by 2027, at a CAGR of 6.8% during a forecast
period.

Introduction and Market dynamics:

Cardiovascular disorder contains conditions that narrow or block blood vessels


(coronary heart disease). This can cause a heart attack, angina, and a few
strokes. The report study has analyzed revenue impact of COVID -19 pandemic on
the sales revenue of market leaders, market followers and market disrupters in
the report and same is reflected in our analysis. By Device,
Electrocardiography (ECG) segment was valued at USD XX Mn. in 2019 and is
expected to reach USD XX Mn. by 2027 at a CAGR of XX% during the forecast
period. In North America the cardiovascular devices market is majorly
stimulated by the changes or the sifting in the trend of the technology that
permits the players to develop modern devices. The many players are getting
several approvals for the cardiovascular devices for example, Medtronic,
Abbott and W. L. Gore & Associates has received approvals for products.

The market for these cardiovascular devices is impelled by way of the


excessive incidence of the target disorder because of unhealthy living habits
such as smoking, consumption of alcohol, and hypertension, together with a
growing geriatric populace. The changing life and upward thrust inside the
geriatric population is identified as primary reason behind the threat of
cardiovascular problems. Cardiovascular sicknesses (CVDs) are the number one
cause of death globally, taking a predicted 17.9 million lives every year.

Proper medical transformations together with suitable value-powerful


treatments supported with insurance and reimbursements have shaped the growth
curve. Also, planned acquisitions and mergers together with the number one
product launches have fostered the market. Heart diseases, together with
coronary heart disease, heart attack, congestive coronary heart failure, and
congenital coronary heart disease, are the main reason of death for women and
men within the U.S. The novel product helps in augmenting higher results for
health and lives a better existence. The market is associated with numerous
marketplace leaders who are conducting various developmental activities for
cardiovascular devices. For example, the mobile cardiac telemetry (MCT) system
is a revolutionary product this is helping cardiac patients to monitor their
heart condition. The mobile cardiac telemetry is a small sensor and monitor
that patients put on in their daily life.
However, adverse trade relations, excessive value of device maintenance and
shortage of professional personnel have become prime source of limitations to
the market.

Global Cardiovascular Device Market Segment analysis

By Device, Electrocardiography ECG holds at least 40% of the share, and this
will be credited to the improved capacities of the new generation
Electrocardiograms. On the diagnostic and tracking front, a brand new
technology of portable and compact ECG is impelling its greater adoption, in
particular inside the home healthcare phase. There has been an upsurge in the
occurrence of cardiovascular diseases (CVD), wherein a long-term ECG
monitoring is vital and with the introduction of wireless ECG, doctors can
monitor and diagnose the patient remotely on time, which further boost the
market growth. Besides, growing cardiovascular illnesses, consisting of
arrhythmias, stroke, and excessive blood pressure, are growing the demand for
cardiovascular devices; in consort with mounting cognizance and demand for
minimally invasive surgeries are also anticipated to thrust the cardiovascular
device market.

In 2019, coronary heart disease held the most important market share of 41.9%
of the cardiovascular devices market, by application. The coronary heart
disease segment is expected to rule its market share in 2027 because of the
growing incidence of the disease.

Global Cardiovascular Device Market Regional analysis

The North America cardiovascular device market was valued at US$ XX million in
2019 and is expected to reach a value of US$ XX million by 2027, with a CAGR
of XX% during the forecast period. The increase of the cardiovascular devices
market is mainly accredited to the growing developments for cardiovascular
devices and the up surging aged populace. On the contradictory hand, mounting
medical tourism in Mexico is probably to have a fantastic impact on the growth
of the North American cardiovascular devices market in the upcoming years. The
cardiovascular devices market is majorly promoted by the changes or the
sifting in the trend of the technology that permits the players to develop
modern devices. The market is associated with numerous market leaders that are
carrying out numerous developmental activities for cardiovascular devices.
According to the American College of Cardiology, cardiovascular disorder (CVD)
accounted for 800,000 deaths in the United States in 2017 alone.

The Asia Pacific is anticipated to see the fastest growth during the forecast
period with Japan expected leading the general Asia Pacific market, followed
by China. China is predicted to have the largest geriatric population globally
with the highest obesity problem rates as a result of inactive life and bad
dietary habits. These factors are expected to raise the superiority of cardiac
diseases in this country, therefore definitely impacting the growth of the
Asia Pacific market. The mounting nations are substantially growing their
healthcare centers and offerings and are directing towards technological
improvements. For example, the structural heart is on the initial stage of the
activities improvement in regions such as the Asia Pacific and the Middle East
and Africa.

Key Development

• In August 2018, Boston Scientific Corporation acquired Claret Medical Inc.


to take advantage of the product range of the acquired company which produces
devices protect patients from the threat of being affected by stroke after
valve replacement surgeries.

• In June 2018, LivaNova plc received an approval for advanced technological


developments in surgical options for the treatment of the aortic valve
diseases from the Japanese Minister of Health, Labor and Welfare.

The objective of the report is to present a comprehensive analysis of the


Global Cardiovascular Device Market including all the stakeholders of the
industry. The past and current status of the industry with forecasted market
size and trends are presented in the report with the analysis of complicated
data in simple language. The report covers all the aspects of the industry
with a dedicated study of key players that includes market leaders, followers
and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of
micro-economic factors of the market has been presented in the report.
External as well as internal factors that are supposed to affect the business
positively or negatively have been analysed, which will give a clear
futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Cardiovascular Device Market


dynamics, structure by analysing the market segments and projects the Global
Cardiovascular Device Market size. Clear representation of competitive
analysis of key players by Application, price, financial position, Product
portfolio, growth strategies, and regional presence in the Global
Cardiovascular Device Market make the report investor’s guide.

Scope of the Global Cardiovascular Device


Market

Global Cardiovascular Device Market, By Device

• Electrocardiography (ECG)
• Stent
• Defibrillator
• Cardiac Catheter
• Guide wire
• Event Monitor
• Heart Valve
• Pacemaker
• Others

Global Cardiovascular Device Market, By Application


• Stroke
• Cerebrovascular Heart Disease
• Coronary Heart Disease
• Sudden Cardiac Arrest
• Others

Global Cardiovascular Device Market, By End-User

• Cardiac Centers
• Hospitals
• Ambulatory Surgical Centers

Global Cardiovascular Device Market, By Regions

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa (MEA)

Key Players operating the Global Cardiovascular Device


Market

• Siemens AG
• BD
• B. Braun Melsungen AG
• Edwards Lifesciences Corporation
• Medtronic
• Biosense Webster, Inc (Johnson and Johnson)
• General Electric Company
• Koninklijke Philips N.V
• Boston Scientific Corporation
• Abbott
• Jarvik Heart
• Maquet Cardiovascular
• Merit Medical Systems
• On-X Life Technologies
• Orbusneich
• St. Jude Medical
• Sorin Group
• Spectranetics
• Sunshine Heart
• Syncardia Systems
• Thoratec
• Volcano

Das könnte Ihnen auch gefallen